Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 2Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroendocrine Tumors 1Multiple Myeloma 1Inflammatory Breast Neoplasms 1

Interventions

Bevacizumab 6Everolimus 4Sirolimus 2Lapatinib 2HDAC-42 2vistusertib 1temsirolimus 1neratinib 1icotinib 1emvododstat 1brolucizumab 1brigatinib 1aflibercept 1Vascular Endothelial Growth Factor A 1Valproic Acid 1Sunitinib 1Magnetic Resonance Imaging 1Immunoglobulin G 1Exome 1Endostatins 1Doxycycline 1Disulfides 1Crizotinib 1Cetuximab 1Axitinib 1Aspirin 1AZD 6244 189Zr-bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 2 × 89Zr-bevacizumab × Clear all
NCT05685836 2024-03-20

89Zr-Bevacizumab PET/CT Imaging in NF2 Patients

Leiden University Medical Center

Unknown
15 enrolled
CNS

Neuroma, Acoustic, Neurofibromatosis 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡